Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche obtains EC approval for Tecentriq/Avastin to treat liver cancer

pharmaceutical-technologyNovember 05, 2020

Tag: Roche , Tecentriq , Avastin , Liver cancer , HCC

PharmaSources Customer Service